Multimodal Strategies to Fight Obesity: Research on Tailored Therapies Based on Natural and Synthetic Compounds for Prevention, Management and Treatment
Author Contributions
Acknowledgments
Conflicts of Interest
References
- Blüher, M. Obesity: Global Epidemiology and Pathogenesis. Nat. Rev. Endocrinol. 2019, 15, 288–298. [Google Scholar] [CrossRef]
- Caballero, B. Humans against Obesity: Who Will Win? Adv. Nutr. 2019, 10, S4–S9. [Google Scholar] [CrossRef] [Green Version]
- Conway, B.; Rene, A. Obesity as a Disease: No Lightweight Matter. Obes. Rev. 2004, 5, 145–151. [Google Scholar] [CrossRef]
- Allom, V.; Mullan, B.; Smith, E.; Hay, P.; Raman, J. Breaking Bad Habits by Improving Executive Function in Individuals with Obesity. BMC Public Health 2018, 18, 505. [Google Scholar] [CrossRef]
- Khaodhiar, L.; McCowen, K.C.; Blackburn, G.L. Obesity and Its Comorbid Conditions. Clin. Cornerstone 1999, 2, 17–31. [Google Scholar] [CrossRef] [PubMed]
- Morales Camacho, W.J.; Molina Díaz, J.M.; Plata Ortiz, S.; Plata Ortiz, J.E.; Morales Camacho, M.A.; Calderón, B.P. Childhood Obesity: Aetiology, Comorbidities, and Treatment. Diabetes Metab. Res. Rev. 2019, 35, e3203. [Google Scholar] [CrossRef] [PubMed]
- D’Anneo, A.; Lauricella, M. Natural and Synthetic Compounds for Management, Prevention and Treatment of Obesity. Int. J. Mol. Sci. 2022, 23, 2890. [Google Scholar] [CrossRef]
- Karczewski, J.; Śledzińska, E.; Baturo, A.; Jończyk, I.; Maleszko, A.; Maleszko, A.; Samborski, P.; Begier-Krasińska, B.; Dobrowolska, A. Obesity and Inflammation. Eur. Cytokine Netw. 2018, 29, 83–94. [Google Scholar] [CrossRef] [PubMed]
- Kawai, T.; Autieri, M.V.; Scalia, R. Adipose Tissue Inflammation and Metabolic Dysfunction in Obesity. Am. J. Physiol.-Cell Physiol. 2021, 320, C375–C391. [Google Scholar] [CrossRef]
- Hildebrandt, X.; Ibrahim, M.; Peltzer, N. Cell Death and Inflammation during Obesity: “Know My Methods, WAT(Son)”. Cell Death Differ. 2023, 30, 279–292. [Google Scholar] [CrossRef]
- Longo, M.; Zatterale, F.; Naderi, J.; Parrillo, L.; Formisano, P.; Raciti, G.A.; Beguinot, F.; Miele, C. Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications. Int. J. Mol. Sci. 2019, 20, 2358. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ghaben, A.L.; Scherer, P.E. Adipogenesis and Metabolic Health. Nat. Rev. Mol. Cell Biol. 2019, 20, 242–258. [Google Scholar] [CrossRef] [PubMed]
- Liu, R.; Nikolajczyk, B.S. Tissue Immune Cells Fuel Obesity-Associated Inflammation in Adipose Tissue and Beyond. Front. Immunol. 2019, 10, 1587. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Trayhurn, P. Hypoxia and Adipose Tissue Function and Dysfunction in Obesity. Physiol. Rev. 2013, 93, 1–21. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sakers, A.; De Siqueira, M.K.; Seale, P.; Villanueva, C.J. Adipose-Tissue Plasticity in Health and Disease. Cell 2022, 185, 419–446. [Google Scholar] [CrossRef] [PubMed]
- Marcelin, G.; Gautier, E.L.; Clément, K. Adipose Tissue Fibrosis in Obesity: Etiology and Challenges. Annu. Rev. Physiol. 2022, 84, 135–155. [Google Scholar] [CrossRef]
- Keophiphath, M.; Achard, V.; Henegar, C.; Rouault, C.; Clément, K.; Lacasa, D. Macrophage-Secreted Factors Promote a Profibrotic Phenotype in Human Preadipocytes. Mol. Endocrinol. 2009, 23, 11–24. [Google Scholar] [CrossRef] [Green Version]
- Arndt, L.; Lindhorst, A.; Neugebauer, J.; Hoffmann, A.; Hobusch, C.; Alexaki, V.-I.; Ghosh, A.; Blüher, M.; Wolfrum, C.; Glaß, M.; et al. The Role of IL-13 and IL-4 in Adipose Tissue Fibrosis. Int. J. Mol. Sci. 2023, 24, 5672. [Google Scholar] [CrossRef]
- Ugwoke, C.K.; Cvetko, E.; Umek, N. Pathophysiological and Therapeutic Roles of Fascial Hyaluronan in Obesity-Related Myofascial Disease. Int. J. Mol. Sci. 2022, 23, 11843. [Google Scholar] [CrossRef]
- Ostrowska, L.; Smarkusz-Zarzecka, J.; Gornowicz, A.; Lendzion, K.; Zyśk, B.; Pogodziński, D. Analysis of Selected Salivary Adipokines and Cytokines in Patients with Obesity—A Pilot Study. Int. J. Mol. Sci. 2023, 24, 4145. [Google Scholar] [CrossRef]
- Zazula, M.F.; Saraiva, D.F.; Theodoro, J.L.; Maciel, M.; Sepulveda, E.V.d.S.; de Andrade, B.Z.; Boaretto, M.L.; Maciel, J.I.H.N.; Bronczek, G.A.; Soares, G.M.; et al. An Early and Sustained Inflammatory State Induces Muscle Changes and Establishes Obesogenic Characteristics in Wistar Rats Exposed to the MSG-Induced Obesity Model. Int. J. Mol. Sci. 2023, 24, 4730. [Google Scholar] [CrossRef]
- Hernández Bautista, R.J.; Mahmoud, A.M.; Königsberg, M.; López Díaz Guerrero, N.E. Obesity: Pathophysiology, Monosodium Glutamate-Induced Model and Anti-Obesity Medicinal Plants. Biomed. Pharmacother. 2019, 111, 503–516. [Google Scholar] [CrossRef] [PubMed]
- Olney, J.W. Brain Lesions, Obesity, and Other Disturbances in Mice Treated with Monosodium Glutamate. Science 1969, 164, 719–721. [Google Scholar] [CrossRef] [PubMed]
- Quines, C.B.; Rosa, S.G.; Velasquez, D.; Prado, V.C.; Neto, J.S.S.; Nogueira, C.W. (P-ClPhSe)2 Stabilizes Metabolic Function in a Rat Model of Neuroendocrine Obesity Induced by Monosodium Glutamate. Food Chem. Toxicol. 2018, 118, 168–180. [Google Scholar] [CrossRef] [PubMed]
- Livesey, G. Health Potential of Polyols as Sugar Replacers, with Emphasis on Low Glycaemic Properties. Nutr. Res. Rev. 2003, 16, 163–191. [Google Scholar] [CrossRef] [Green Version]
- Bordier, V.; Teysseire, F.; Senner, F.; Schlotterbeck, G.; Drewe, J.; Beglinger, C.; Wölnerhanssen, B.K.; Meyer-Gerspach, A.C. Absorption and Metabolism of the Natural Sweeteners Erythritol and Xylitol in Humans: A Dose-Ranging Study. Int. J. Mol. Sci. 2022, 23, 9867. [Google Scholar] [CrossRef]
- DiNicolantonio, J.J.; O’Keefe, J.H. Good Fats versus Bad Fats: A Comparison of Fatty Acids in the Promotion of Insulin Resistance, Inflammation, and Obesity. Mo. Med. 2017, 114, 303–307. [Google Scholar] [PubMed]
- Ishaq, A.; Tchkonia, T.; Kirkland, J.L.; Siervo, M.; Saretzki, G. Palmitate Induces DNA Damage and Senescence in Human Adipocytes in Vitro That Can Be Alleviated by Oleic Acid but Not Inorganic Nitrate. Exp. Gerontol. 2022, 163, 111798. [Google Scholar] [CrossRef]
- De Blasio, A.; D’Anneo, A.; Lauricella, M.; Emanuele, S.; Giuliano, M.; Pratelli, G.; Calvaruso, G.; Carlisi, D. The Beneficial Effects of Essential Oils in Anti-Obesity Treatment. Int. J. Mol. Sci. 2021, 22, 11832. [Google Scholar] [CrossRef]
- Pratelli, G.; Carlisi, D.; D’Anneo, A.; Maggio, A.; Emanuele, S.; Palumbo Piccionello, A.; Giuliano, M.; De Blasio, A.; Calvaruso, G.; Lauricella, M. Bio-Waste Products of Mangifera indica L. Reduce Adipogenesis and Exert Antioxidant Effects on 3T3-L1 Cells. Antioxidants 2022, 11, 363. [Google Scholar] [CrossRef]
- Lo Galbo, V.; Lauricella, M.; Giuliano, M.; Emanuele, S.; Carlisi, D.; Calvaruso, G.; De Blasio, A.; Di Liberto, D.; D’Anneo, A. Redox Imbalance and Mitochondrial Release of Apoptogenic Factors at the Forefront of the Antitumor Action of Mango Peel Extract. Molecules 2021, 26, 4328. [Google Scholar] [CrossRef] [PubMed]
- Lauricella, M.; Lo Galbo, V.; Cernigliaro, C.; Maggio, A.; Palumbo Piccionello, A.; Calvaruso, G.; Carlisi, D.; Emanuele, S.; Giuliano, M.; D’Anneo, A. The Anti-Cancer Effect of Mangifera indica L. Peel Extract Is Associated to ΓH2AX-Mediated Apoptosis in Colon Cancer Cells. Antioxidants 2019, 8, 422. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sferrazzo, G.; Palmeri, R.; Restuccia, C.; Parafati, L.; Siracusa, L.; Spampinato, M.; Carota, G.; Distefano, A.; Di Rosa, M.; Tomasello, B.; et al. Mangifera indica L. Leaves as a Potential Food Source of Phenolic Compounds with Biological Activity. Antioxidants 2022, 11, 1313. [Google Scholar] [CrossRef] [PubMed]
- Pratelli, G.; Di Liberto, D.; Carlisi, D.; Emanuele, S.; Giuliano, M.; Notaro, A.; De Blasio, A.; Calvaruso, G.; D’Anneo, A.; Lauricella, M. Hypertrophy and ER Stress Induced by Palmitate Are Counteracted by Mango Peel and Seed Extracts in 3T3-L1 Adipocytes. Int. J. Mol. Sci. 2023, 24, 5419. [Google Scholar] [CrossRef] [PubMed]
- Li, L.; Zhu, G.; Fu, G.; Zha, W.; Li, H. Metabolic Syndrome Ameliorated by 4-Methylesculetin by Reducing Hepatic Lipid Accumulation. Int. J. Mol. Sci. 2022, 23, 10465. [Google Scholar] [CrossRef] [PubMed]
- Scazzocchio, B.; Minghetti, L.; D’Archivio, M. Interaction between Gut Microbiota and Curcumin: A New Key of Understanding for the Health Effects of Curcumin. Nutrients 2020, 12, 2499. [Google Scholar] [CrossRef]
- Panahi, Y.; Khalili, N.; Sahebi, E.; Namazi, S.; Simental-Mendía, L.; Majeed, M.; Sahebkar, A. Effects of Curcuminoids Plus Piperine on Glycemic, Hepatic and Inflammatory Biomarkers in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blind Placebo-Controlled Trial. Drug Res. 2018, 68, 403–409. [Google Scholar] [CrossRef]
- Servida, S.; Panzeri, E.; Tomaino, L.; Marfia, G.; Garzia, E.; Appiani, G.C.; Moroncini, G.; Colonna, V.D.G.; Vecchia, C.L.; Vigna, L. Overview of Curcumin and Piperine Effects on Glucose Metabolism: The Case of an Insulinoma Patient’s Loss of Consciousness. Int. J. Mol. Sci. 2023, 24, 6621. [Google Scholar] [CrossRef]
- Terzo, S.; Amato, A.; Mulè, F. From Obesity to Alzheimer’s Disease through Insulin Resistance. J. Diabetes Complicat. 2021, 35, 108026. [Google Scholar] [CrossRef]
- Terzo, S.; Calvi, P.; Nuzzo, D.; Picone, P.; Allegra, M.; Mulè, F.; Amato, A. Long-Term Ingestion of Sicilian Black Bee Chestnut Honey and/or D-Limonene Counteracts Brain Damage Induced by High Fat-Diet in Obese Mice. Int. J. Mol. Sci. 2023, 24, 3467. [Google Scholar] [CrossRef]
- D’Antongiovanni, V.; Fornai, M.; Pellegrini, C.; Blandizzi, C.; Antonioli, L. Managing Obesity and Related Comorbidities: A Potential Pharmacological Target in the Adenosine System? Front. Pharmacol. 2021, 11, 621955. [Google Scholar] [CrossRef] [PubMed]
- Carrageta, D.F.; Dias, T.R.; Alves, M.G.; Oliveira, P.F.; Monteiro, M.P.; Silva, B.M. Anti-Obesity Potential of Natural Methylxanthines. J. Funct. Foods 2018, 43, 84–94. [Google Scholar] [CrossRef]
- Kotańska, M.; Dziubina, A.; Szafarz, M.; Mika, K.; Bednarski, M.; Nicosia, N.; Temirak, A.; Müller, C.E.; Kieć-Kononowicz, K. Preliminary Evidence of the Potent and Selective Adenosine A2B Receptor Antagonist PSB-603 in Reducing Obesity and Some of Its Associated Metabolic Disorders in Mice. Int. J. Mol. Sci. 2022, 23, 13439. [Google Scholar] [CrossRef] [PubMed]
- Malmlöf, K.; Golozoubova, V.; Peschke, B.; Wulff, B.S.; Refsgaard, H.H.F.; Johansen, P.B.; Cremers, T.; Rimvall, K. Increase of Neuronal Histamine in Obese Rats Is Associated with Decreases in Body Weight and Plasma Triglycerides. Obesity 2006, 14, 2154–2162. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Malmlöf, K.; Zaragoza, F.; Golozoubova, V.; Refsgaard, H.H.F.; Cremers, T.; Raun, K.; Wulff, B.S.; Johansen, P.B.; Westerink, B.; Rimvall, K. Influence of a Selective Histamine H3 Receptor Antagonist on Hypothalamic Neural Activity, Food Intake and Body Weight. Int. J. Obes. 2005, 29, 1402–1412. [Google Scholar] [CrossRef] [Green Version]
- Mika, K.; Szafarz, M.; Zadrożna, M.; Nowak, B.; Bednarski, M.; Szczepańska, K.; Pociecha, K.; Kubacka, M.; Nicosia, N.; Juda, I.; et al. KSK-74: Dual Histamine H3 and Sigma-2 Receptor Ligand with Anti-Obesity Potential. Int. J. Mol. Sci. 2022, 23, 7011. [Google Scholar] [CrossRef]
- Cruciani, S.; Delitala, A.P.; Cossu, M.L.; Ventura, C.; Maioli, M. Management of Obesity and Obesity-Related Disorders: From Stem Cells and Epigenetics to Its Treatment. Int. J. Mol. Sci. 2023, 24, 2310. [Google Scholar] [CrossRef]
- Cawthorn, W.P.; Scheller, E.L.; MacDougald, O.A. Adipose Tissue Stem Cells Meet Preadipocyte Commitment: Going Back to the Future. J. Lipid Res. 2012, 53, 227–246. [Google Scholar] [CrossRef] [Green Version]
- Szymczak-Pajor, I.; Miazek, K.; Selmi, A.; Balcerczyk, A.; Śliwińska, A. The Action of Vitamin D in Adipose Tissue: Is There the Link between Vitamin D Deficiency and Adipose Tissue-Related Metabolic Disorders? Int. J. Mol. Sci. 2022, 23, 956. [Google Scholar] [CrossRef]
- Ammendola, S.; Scotto d’Abusco, A. Nutraceuticals and the Network of Obesity Modulators. Nutrients 2022, 14, 5099. [Google Scholar] [CrossRef]
- Santaniello, S.; Cruciani, S.; Basoli, V.; Balzano, F.; Bellu, E.; Garroni, G.; Ginesu, G.C.; Cossu, M.L.; Facchin, F.; Delitala, A.P.; et al. Melatonin and Vitamin D Orchestrate Adipose Derived Stem Cell Fate by Modulating Epigenetic Regulatory Genes. Int. J. Med. Sci. 2018, 15, 1631–1639. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cruciani, S.; Garroni, G.; Balzano, F.; Pala, R.; Bellu, E.; Cossu, M.L.; Ginesu, G.C.; Ventura, C.; Maioli, M. Tuning Adipogenic Differentiation in ADSCs by Metformin and Vitamin D: Involvement of MiRNAs. Int. J. Mol. Sci. 2020, 21, 6181. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
D’Anneo, A.; Lauricella, M. Multimodal Strategies to Fight Obesity: Research on Tailored Therapies Based on Natural and Synthetic Compounds for Prevention, Management and Treatment. Int. J. Mol. Sci. 2023, 24, 10105. https://doi.org/10.3390/ijms241210105
D’Anneo A, Lauricella M. Multimodal Strategies to Fight Obesity: Research on Tailored Therapies Based on Natural and Synthetic Compounds for Prevention, Management and Treatment. International Journal of Molecular Sciences. 2023; 24(12):10105. https://doi.org/10.3390/ijms241210105
Chicago/Turabian StyleD’Anneo, Antonella, and Marianna Lauricella. 2023. "Multimodal Strategies to Fight Obesity: Research on Tailored Therapies Based on Natural and Synthetic Compounds for Prevention, Management and Treatment" International Journal of Molecular Sciences 24, no. 12: 10105. https://doi.org/10.3390/ijms241210105